Attention Seniors: Diploma Presenters for GraduationEvery year, each graduate is given the opportunity to choose a diploma presenter who has been influential in his/her life. The special person that each senior selects must be a current or former Worthington City Schools employee. The person you select will be invited to present your diploma to you at Commencement in May 2021.
In order to request the person you would like as your diploma presenter, you must turn in your request using this Diploma Presenter Request Google Form no later than Friday, March 26, 2021. The form can be found on your class Schoology page and other senior graduation communications.
There is NO need to ask the person you are requesting ahead of time. The diploma presenter coordinator, Mrs. Wilson, will do that for you. Due to the time and effort involved in inviting these individuals and in organizing this addition to the Commencement ceremony, your cooperation in meeting this deadline is imperative. If you do not request a guest presenter, a member of the Worthington Board of Education will present your diploma. Please see Mrs. Wilson, Room 198, or email her at [email protected], with any questions concerning this process
March is Women’s History Month. Throughout this month we will highlight some of the various contributions of women around the world.
Kizzmekia “Kizzy” Shanta Corbett is an American viral immunologist at the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID NIH) based in Bethesda, Maryland. She is currently the scientific lead of the VRC’s Coronavirus Team, with research efforts aimed at propelling novel coronavirus vaccines, including a COVID-19 vaccine. In December 2020, the Institute’s Director, Dr. Anthony Fauci said: “Kizzy is an African American scientist who is right at the forefront of the development of the vaccine.” In February 2021, Corbett was highlighted in Time’s “Time100 Next” list. In the Time’s profile, Dr. Fauci wrote that Corbett has “been central to the development of the Moderna mRNA vaccine and the Eli Lilly therapeutic monoclonal antibody that were first to enter clinical trials in the U.S.” and that “her work will have a substantial impact on ending the worst respiratory-disease pandemic in more than 100 years.”